This CGM will track your body's response - Could personalised glucose data inform your body’s metabolism and performance?

Looking forward, DexCom's management has reiterated its fiscal year 2025 forecast, anticipating revenue growth of 14% with a Non-GAAP operating margin goal of around 21%. The approval and expected ...

A U.K. court has ruled against Abbott in a trademark infringement case the company had brought over the design of a rival ...

Germantown, Maryland Monday, February 10, 2025, 16:00 Hrs [IST] ...

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...

Dexcom, Inc.'s (NASDAQ:DXCM) fourth-quarter revenue rose 8% year-over-year to $1.114 billion, beating the analyst consensus ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of ...

Sales: The California-based device maker is pinning its hopes on Stelo, its recently launched device for adults aged 18 and ...

An innovative study, co-designed by Aboriginal Women, has led to remission of type 2 diabetes. The research described and ...